t(1;5)(q23;q33) in a patient with high-risk B-lineage acute lymphoblastic leukemia
dc.contributor.author | Barriga, F | |
dc.contributor.author | Bertin, P | |
dc.contributor.author | Legues, E | |
dc.contributor.author | Risueno, C | |
dc.contributor.author | Andrade, W | |
dc.contributor.author | Cabrera, E | |
dc.contributor.author | Grebe, G | |
dc.date.accessioned | 2025-01-21T01:34:07Z | |
dc.date.available | 2025-01-21T01:34:07Z | |
dc.date.issued | 1996 | |
dc.description.abstract | The t(1;5)(q23;q33) is a rare genetic anomaly that was reported previously in two infants with a myeloproliferative disorder and eosinophilia and in one adult patient with acute nonlymphocytic leukemia (ANLL). A 13-year-old boy with high-risk early pre-B acute lymphoblastic leukemia (ALL) who presented to our institution carried the t(1;5)(q23;q33). He had an initial blast count of 230 x 10(9)/L and responded poorly to prednisone. Complete remission ICR) was achieved, and he had a bone marrow (BM) relapse 3 months after despite intensive consolidation therapy He underwent allogeneic BM transplantation (BMT) from a human leukocyte antigen (HLA)-identical sibling in early relapse with total body irradiation (TBI) and cyclophosphamide conditioning. He had a short second CR with a central nervous system (CNS) relapse on day +106 after BMT. Two of the previously reported patients also did not respond to chemotherapy. The t(1;5)(q23;q33) appears to be a rare lineage nonspecific anomaly related to hematologic malignancies that are resistant to current therapy. | |
dc.fuente.origen | WOS | |
dc.identifier.issn | 0165-4608 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/97516 | |
dc.identifier.wosid | WOS:A1996UD43100002 | |
dc.issue.numero | 1 | |
dc.language.iso | en | |
dc.pagina.final | 6 | |
dc.pagina.inicio | 4 | |
dc.revista | Cancer genetics and cytogenetics | |
dc.rights | acceso restringido | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | t(1;5)(q23;q33) in a patient with high-risk B-lineage acute lymphoblastic leukemia | |
dc.type | artículo | |
dc.volumen | 87 | |
sipa.index | WOS | |
sipa.trazabilidad | WOS;2025-01-12 |